TORONTO, April 8 /CNW/ - Theralase Technologies Inc. (TSX-V: TLT), a designer, manufacturer and distributor of therapeutic medical laser and light-based systems, today announced that a European pharmaceutical company has commissioned Theralase to contract manufacture ten beta prototype photodynamic therapy (PDT) light-based systems for delivery in the second and third quarter of 2008.
